A rare outbreak of tuberculosis among dozens of surgical patients — some of them at hospitals in northern Virginia — is under investigation by federal health authorities, including the Centers for Disease Control and Prevention. The CDC suspects the infections may be tied to a malleable bone putty used in spinal and other orthopedic procedures.
The substance includes human cells harvested from cadavers, according to Aziyo Biologics Inc., a regenerative medicine company that has voluntarily recalled 154 containers of its FiberCel product.
Patrick Malone & Associates represents patients infected with tuberculosis apparently from this FiberCel bone putty product. Our firm is actively investigating what happened to determine the legal liability of everyone involved and to see where the breakdowns occurred in the checks and balances intended to keep medical products safe.